EUVIMEDEUVIMED entdecken
Crossref

Quality assurance of SARS-CoV-2 testing laboratories during the pandemic period in India – An experience from a designated provider laboratory

Vikas Manchanda, Oves Siddiqui, Kavita Meena, Anju Sharma, Sonal Saxena

Indian Journal of Medical Microbiology · 2024

DOI: 10.1016/j.ijmmb.2024.100577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Medical Microbiology, 2024. Verfasst von Vikas Manchanda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Maulana Azad Medical College & Associated Lok Nayak Hospital, Bahadur Shah Zafar Marg, New Delhi, 110002, India; State Le…. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, COVID-19 Testing. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Indian Council of Medical Research (ICMR) initiated an Inter-Laboratory Quality Control testing (ILQC) program for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) testing. Under this program, SARS-CoV-2 testing laboratories across the country submit specimens to the assigned State Quality Control (SQCs) laboratories for ILQC testing. This study aimed to investigate the performance of public and private SARS-CoV-2 testing laboratories in Delhi and highlights the country's effort in ramping up testing facility with close monitoring of the quality of Covid-19 testing results. METHODS: In the present study, two-years of SARS-CoV-2 testing data is included. During July 2020 through February 2022, a total of 1791 anonymised specimens were received from 56 public and private laboratories. These specimens were processed by reverse transcriptase - polymerase chain reaction (RT-PCR) tests as per National Institute of Virology (NIV) protocol and the results were uploaded on the ICMR quality control/quality assurance (QC/QA) portal without directly conveying the results to respective participating laboratories. This portal generated a final report stating concordance and intimate results to individual laboratories. RESULTS: Among the 1791 specimens, 25 were rejected and the remaining 1766 were tested. Among these specimens 1691 (95.75%) revealed concordance, and 75 (4.24%) were discordant. A total of 29 laboratories had 100% concordance, 21 laboratories had over 90% concordance and six laboratories had over 80% concordance. CONCLUSIONS: The study demonstrates that the establishment of an inter-laboratory comparison program for SARS-CoV-2 testing helped in monitoring quality of SARS-CoV-2 testing in the country.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2COVID-19 TestingHumansIndiaQuality ControlQuality Assurance, Health CareLaboratoriesLaboratories, ClinicalPandemics

Stichwörter der Autor:innen

ICMR-NIVILQCQC/QASARS-CoV-2SQC

Autor:innen und Institutionen

  • Department of Microbiology, Maulana Azad Medical College & Associated Lok Nayak Hospital, Bahadur Shah Zafar Marg, New Delhi, 110002, India; State Level -Viral Research and Diagnostic Laboratory (VRDL), Department of Mi…
  • Department of Microbiology, Maulana Azad Medical College & Associated Lok Nayak Hospital, Bahadur Shah Zafar Marg, New Delhi, 110002, India. Electronic address: kavitachirawat@gmail.com.
  • State Level -Viral Research and Diagnostic Laboratory (VRDL), Department of Microbiology, Maulana Azad Medical College & Associated Lok Nayak Hospital, Bahadur Shah Zafar Marg, New Delhi, 110002, India. Electronic addre…

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Manchanda, V., Siddiqui, O., Meena, K., Sharma, A., & Saxena, S. (2024). Quality assurance of SARS-CoV-2 testing laboratories during the pandemic period in India – An experience from a designated provider laboratory. Indian Journal of Medical Microbiology. https://doi.org/10.1016/j.ijmmb.2024.100577

Vancouver

Manchanda V, Siddiqui O, Meena K, Sharma A, Saxena S. Quality assurance of SARS-CoV-2 testing laboratories during the pandemic period in India – An experience from a designated provider laboratory. Indian Journal of Medical Microbiology. 2024. doi:10.1016/j.ijmmb.2024.100577

BibTeX
@article{Manchanda2024,
  author = {Manchanda, Vikas and Siddiqui, Oves and Meena, Kavita and Sharma, Anju and Saxena, Sonal},
  title = {Quality assurance of SARS-CoV-2 testing laboratories during the pandemic period in India – An experience from a designated provider laboratory},
  journal = {Indian Journal of Medical Microbiology},
  year = {2024},
  doi = {10.1016/j.ijmmb.2024.100577}
}
Kostenlos starten →